Open Course 2017
Medical Industry Innovation Forum
The 2017 forum is over.
[Theme] Will multidisciplinary collaboration lead the way to new medical solutions?
Dates
October 14th, 2017 – March 20th ,2018 (7 sessions)
18:00 – 20:00 (*Nov.21th and Jan.30th 18:00-21:00) (A reception will be held after each lecture)
Location
Tetsumon Memorial Hall
(14th Floor, Faculty of Medicine Experimental Research Building)
Target Audience
200 people
- Undergraduate and graduate students (from The University of Tokyo and other universities)
- Medical Innovation Industry Institute members
- Healthcare professionals from medical institutes, academic societies, industries including pharmaceutical and medical device companies
- Other professionals with a strong interest in leading Innovation in the medical industry
Registration Fee
Please pay the fee via a single bank transfer payment. We will provide the account information at a later date
- Regular: 35,000JPY
- Mi3 Member: 17,000JPY (It costs extra, annual membership fee 12,000 yen)
- Student: Free, for 7 lectures. (Working students, please register in general)
Course Description
Lately, in the field of life science healthcare, not only is there an increase in the collaboration between medicine, engineering, and pharmacology, but also an increase in cooperation across the industrial, academic, and government sectors.
More and more, the evolving synergies between ICT, IoT, big data, and AI has expanded the future possibilities in the industry.
Meanwhile, the demand for medical innovations is ever increasing; not only to extend healthy living (QOL), but also to improve healthcare financing programs.
This year’s forum will discuss the latest trends in co-creation ( networking and diversified collaboration) within the life science and healthcare fields, as well as the ways to break through the barriers hindering the implementation of innovations, to the benefit of society.
Contact Information
Forum office within Medical Innovation Industry Institute
Tel: +81-3-5842-3363
Presented by Pharmaco-Business Innovation, Graduate School of Pharmaceutical Sciences, the University of Tokyo (Professor: Hiromichi Kimura).
The Forum is sponsored by the Medical Innovation Industry Institute
Program
Oct.24th（Tue）
Hiromichi Kimura
The University of Tokyo
Visiting Professor
Koji Tamada
Department of Immunology, Yamaguchi University Graduate School of Medicine
Professor
Naoto Kondo
RIKEN GENESIS CO., LTD.
President and CEO
Haruhiko Hakuno
Health, Ministry of Health, Labour and Welfare
Nov.14th（Tue）
Osamu Nureki
Department of Biological Sciences, Graduate School of Science,The University of Tokyo
Professor
Yutaka Hanazono
Development of Advanced Medical Technology, Jichi Medical University
Director and Professor
Nov. 21st（Tue）”Special”
Kazuya Onomichi
Ajinomoto Co., INC.
Corporate Vice President
Yoshiyuki Tanaka
Du Pont Kabushiki Kaisha
President
Takashi Matsumoto
Compass to Healthy Life Research Complex Program, RIKEN
Group Director
(NineSigma Japan, Inc. Vice President)
Nov.28th（Tue）
Nov.28th（Tue）
Advantage Risk Management Co.,Ltd
President
Tsutahiro Hamaguchi
University of Occupational and Environmental Health part-time Professor
Firm & Brain co. Executive Director
Seiji Nishino
Psychiatry and Behavioral Sciences, Stanford University School of Medicine Professor
Sleep & Circadian Neurobiology Laboratory Director
Dec.12nd（Tue）
Toshihiko Takeda
Health, Ministry of Health, Labour and Welfare
Director-General
Masaya Watanabe
Healthcare Business Unit, Hitachi, Ltd.
Vice President and Executive Officer, CEO
Kiyohito Nakai
Director, Medical Device Evaluation Division
Pharmaceutical Safety and Environmental Health Bureau
Ministry of Health, Labor and Welfare
Jan. 30th（Tue）
Hiromichi Kimura
The University of Tokyo
Visiting Professor
Maki Sugimoto
Graduate School, International University of Health and Welfare
Associate Professor
HoloEyes Inc. Founder, COO
Yutaka Matsuo
Graduate School of Engineering, The University of Tokyo
Project Associate Professor
Feb.13th（Tue）
Kenji Kawachi
NewHeart Watanabe Institute
CEO
Yasuhiro Suzuki
Health, Ministry of Health, Labour and Welfare
Chief Medical & Global Health Officer, Vice-Minister
Mar.20th（Tue）
Greg Behar
Nestle Health Science CEO
Tadaatsu Hanadate
Corporate Planning, Astellas Pharma Inc.
Senior Manager
Hiroshi Kiyono, D.D.S., Ph.D.
Professor and Director,
Division of Mucosal Immunology,Department of Microbiology and Immunology,The Institute of Medical Science, The University of Tokyo
Director and Professor,
International Research & Development Center for Mucosal Vaccines,The Institute of Medical Science, The University of Tokyo
Mar.27th（Tue） “Special”
Nobuhiko Okabe
Director General
Kawasaki City Institute for Public Health
Tetsuo Nakayama
Project Professor
Kitasato Institute for Life Sciences
Chikara Kikuchi
Sr. Director, Japan Regulatory Affairs, Development Japan, Pfizer Japan Inc.
Ryosuke Tsuchiya
Former Chair Person, Kanagawa Prefectural Hospital Organization
Yumiko Mochizuki
Associate Director for Tobacco Free Japan and Business Development
Japan Cancer Society
Tetsuro Ishii
Vice President,
Corporate and Regulatory Affairs Division, Tobacco Business Headquarters, Japan Tobacco Inc.
Kyoko Murakami
Cooperate Affairs
Health outcome research RRP Manager
Philip Morris Japan LTD